Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | REGN6569 |
Synonyms | |
Therapy Description |
REGN6569 is a monoclonal antibody that binds to and activates the glucocorticoid-induced tumor necrosis factor receptor (GITR, TNFRSF18) expressed on immune cells, potentially leading to activation and proliferation of effector T cells and anti-tumor immune response (J Clin Oncol 42, 2024 (suppl 16; abstr 2650, NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
REGN6569 | REGN-6569|REGN 6569 | GITR Antibody 7 | REGN6569 is a monoclonal antibody that binds to and activates the glucocorticoid-induced tumor necrosis factor receptor (GITR, TNFRSF18) expressed on immune cells, potentially leading to activation and proliferation of effector T cells and anti-tumor immune response (J Clin Oncol 42, 2024 (suppl 16; abstr 2650, NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|